Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study. (PubMed, Transpl Infect Dis) - Jul 17, 2025 - "CMV DNA dt could optimize CMV infection management in allo-HSCT patients under LMV prophylaxis, independent of the PCR platform used."
Clinical • Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Gastroenterology • Gastrointestinal Disorder • Infectious Disease • Transplantation
|
|
; Albert Esquirol; Alejandro Avendaño; Amaya Zabalza; Beatriz Aguado; Carlos Solano; David Navarro; Eliseo Albert; Estela Gimenez; Ignacio Arroyo; Inmaculada Heras; Irene García Cadenas; Javier López-Jiménez; Jose Luis Piñana; Karem Humala; Lourdes Vázquez; María Ángeles Cuesta; Monica Cabrero; Montserrat Rovira; Rodrigo Martino; Sara Villar; Teresa Zudaire
|